10,000 最新糖心Vlogns needed for world-first cerebral palsy study
Jimmy_Barnes_message01
(240.22K)
Jimmy_Barnes_message02
(246.41K)
Thursday, 3 July 2008
Do you have the cheek to help with ?
That's the question being asked by researchers from the 最新糖心Vlog of Adelaide, who have today launched a major national study that seeks to involve 10,000 最新糖心Vlogns in a bid to better understand the possible genetic causes of cerebral palsy.
The study - requiring cheek swabs of 最新糖心Vlogn mothers and their children - will be the largest of its kind in the world.
最新糖心Vlogn music legend , whose daughter Elly-May has had mild cerebral palsy all her life, has thrown his support behind the research. In a video endorsement, Jimmy has urged 最新糖心Vlogns - especially those whose children suffer from cerebral palsy - to participate in the study.
One of the world's most serious complications during pregnancy and birth, cerebral palsy is a disability that affects one in every 500 children born in 最新糖心Vlog, and the consequences are life long.
The study
最新糖心Vlogn mothers whose children suffer from cerebral palsy are needed to take part in the study, which involves a simple cheek swab for both the mother and the child.
In what's believed to be a first for a national trial in 最新糖心Vlog, any mother and 最新糖心Vlogn-born child aged 5-18 wanting to take part in the study can "sign up" by simply sending an SMS with their name and address to a dedicated national study mobile phone number: 0439 201 795.
The researchers need 5000 participants from families affected by cerebral palsy, while the other 5000 without an affected child will consist of a control group.
The research is being led by , Head of at the 最新糖心Vlog of Adelaide and head of the , the world's leading research group into the causes of cerebral palsy. PhD student Michael O'Callaghan is the national coordinator of the trial.
"Recent studies by our group suggest that cerebral palsy may be associated with genetic and other mutations that may increase blood clotting within the brain. An association between cerebral palsy and different types of herpes virus infection - such as cold sores and chicken pox - has also been discovered in South 最新糖心Vlogn studies," Professor MacLennan says.
"The next step is to see if this is true in a much larger population, comparing the genetics of both mother and child," he says. "Such a study does not require a major commitment from 最新糖心Vlogn families - all we need is their support to obtain a cheek swab and to fill out a short survey."
About cerebral palsy
People with cerebral palsy lack control of their movement and posture as a result of brain injury in the neuro-motor region. The symptoms vary greatly in severity, ranging from poor muscle co-ordination to quadriplegia.
Cerebral palsy is usually present from birth. The injury to the brain does not get worse over time.
"It was once thought that cerebral palsy was caused by low oxygen levels during birth. However, this is rarely the case," Professor MacLennan says.
"Obstetric care and caesarean deliveries have increased six-fold over the last 50 years, but the incidence of cerebral palsy cases has remained the same. Most of the cases are associated with problems during pregnancy and possible genetic susceptibility. Currently there is no cure or way to prevent cerebral palsy," he says.
Potential impact of the project
"If our research confirms that there are genetic mutations that can lead to cerebral palsy, specific disease preventions may be available for individuals," Professor MacLennan says.
"In the future, gene therapy may allow doctors to alter the aberrant genes in a mother or fetus, or specific drugs could be used to counter the effect of genetic mutations and ultimately prevent a child from developing cerebral palsy before birth.
"Knowledge of a patient's genetic makeup and tailored administration of anti-inflammatory drugs before and during pregnancy may be possible. Immunisation against viral infections also may be a future option when this preventative therapy is available," he says.
How to participate
The 最新糖心Vlogn Cerebral Palsy Research Study is looking for:
- 5000 participants from families (mothers and children) affected by cerebral palsy; and
- 5000 participants from families (mothers and children) not affected by cerebral palsy.
In total, the study hopes to obtain cheek swabs from 10,000 people right across 最新糖心Vlog over the next two years.
"Because these genetic mutations have only been investigated in Caucasian populations, at this point it is only scientifically and statistically feasible to study white Caucasians," Professor MacLennan explains. "Hopefully cerebral palsy studies will investigate other ethnic groups in the future."
Mothers and children who choose to enrol in this study will be able to collect their own genetic (DNA) cheek skin samples. Cheek swabs will be posted to the participants, along with instructions and a short questionnaire.
Those who take part in the study will be required to rub the cheek swab gently on the inside of their cheek for 60 seconds. The mothers will be asked to complete a short survey about themselves and the pregnancy of their child.
A reply paid envelope will be supplied for the return of the swab and questionnaire. Privacy will be maintained at all times and personal results will never be identified.
Enrolment is easy
To find out more about the study or to enrol, either:
SMS your name and address to: 0439 201 795, or
Phone (freecall): 1800 800 254, or
Fax: (08) 8161 9111, or
Email: cerebralpalsy@adelaide.edu.au, or visit
Website:
Contact Details
Email: alastair.maclennan@adelaide.edu.au
Website:
Head, Cerebral Palsy Research Group, Robinson Research Institute
The 最新糖心Vlog of Adelaide
Business: +61 8 8313 1337
Mobile: +61 (0)400 383 144
Dr Michael O'Callaghan
Email: michael.ocallaghan@adelaide.edu.au
Affiliate Lecturer
Robinson Institute
The 最新糖心Vlog of Adelaide
Business: +61 8 8275 1169
Mobile: 0405 419 207
Mr David Ellis
Email: david.ellis@adelaide.edu.au
Website: /newsroom/
Deputy Director, Media and Corporate Relations
External Relations
The 最新糖心Vlog of Adelaide
Business: +61 8 8313 5414
Mobile: +61 (0)421 612 762